Addressing these limitations through standardized, long-term, and phenotype-specific randomized controlled trials is imperative for advancing the field of nutritional OA
Aliquoting into smaller vials with fewer punctures per vial is the best strategy for protocols requiring many doses
Enter product information on the template (maximum number of products: 200)
ADRB2 Rabbit pAb (Cat No: bs-0947R, Lot No: BD06045837), BCL3 Rabbit pAb (Cat No: bs-6591R, Lot No: BD09029500), EGR1 Rabbit pAb (Cat No: bs-1076R, Lot No: BD07036484), FOS Rabbit pAb (Cat No: bs-0469R, Lot No: BD02036587), MAP3K8 Rabbit pAb (Cat No: bs-3591R, Lot No: BD154569821), Cleaved Caspase-3 Rabbit pAb (Cat No: bsm-61090R, Lot No: BE03195616), Caspase-3 Rabbit pAb (Cat No: bs-55032R, Lot No: BD12133918), Caspase-8 Rabbit pAb (Cat No: bs-0052R, Lot No: BD13584563), Fas Associated Via Death Domain ( FADD) Rabbit pAb (Cat No: bs-0511R, Lot No: BD11128696), Gasdermin E ( GSDME) Rabbit pAb (Cat No: bs-14286R, Lot No: BD08082111)